Home News Page 65

News

SGN-CD19A Shows Encouraging Antitumor Activity in Recurrent Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

Results from two ongoing phase I clinical trials evaluating SGN-CD19A (Seattle Genetics), an antibody-drug conjugate or ADC in development for...

AETHERA Trial in Post-Transplant HL Patients Shows Statistically Significant Improvement in Progression-Free Survival

Results from the randomized phase III AETHERA trial (NCT01100502) shows a statistically significant improvement in progression-free survival in Hodgkin lymphoma (HL)...

Expanding Collaboration in Novel Bispecific Antibody Development

Tesaro Inc, an oncology-focused biopharmaceutical company, and AnaptysBio, Inc., a privately-held therapeutic antibody company, agreed to an expansion of...

First-in-human Trial With SYD985 Evaluates Safety and Efficacy in Cancer Patients

Earlier today an initial group of patients with metastatic solid tumors started treatment with an investigational anti-HER2 antibody-drug conjugate...

Menarini and Oxford BioTherapeutics Initiate First-in-Human Study of Enhanced Antibody for Treatment of Acute...

Oxford BioTherapeutics, which is developing a range of innovative ant-cancer antibody-drug conjugates or ADCs based on the company's proprietary Oxford Genome...

AbbVie Acquires Small API Site in Singapore

AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, has acquired a small molecule active pharmaceutical...

New Data on Novel ADC For Solid Cancer Presented at Joint EORTC NCI AACR...

Clinical data on IMMU-132, an anti-TROP-2-SN-38 Anitbody-drug Conjugate currently being evaluated in patients with solid tumors, presented at the 26th EORTC-NCI-AACR...

Seattle Genetics Appoints New General Counsel and Executive Vice President, Legal Affairs

Earlier today, Seattle Genetics, Inc, a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for...

ADC Market to Reach US$ 3 Billion by 2018

According to a report published by Research & Markets, one of the world's largest and most respected market research...

Success of Macromolecular or Nano-sized Bioconjugate Delivery into Cancer Tissue

Developing effective cancer therapy is among the most challenging tasks confronting the scientific community today. One of the major...